Ann Marie Miles, PA-C | |
99 Toiaybe Rd - Kingston, Hc 65 Box 102, Austin, NV 89310 | |
(775) 964-1232 | |
(775) 964-1238 |
Full Name | Ann Marie Miles |
---|---|
Gender | Female |
Speciality | Physician Assistant - Medical |
Location | 99 Toiaybe Rd - Kingston, Austin, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083783674 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | PA 680 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ann Marie Miles, PA-C Hc 65 Box 102, 99 Toiaybe Rd - Kingston, Austin, NV 89310 Ph: (775) 964-1232 | Ann Marie Miles, PA-C 99 Toiaybe Rd - Kingston, Hc 65 Box 102, Austin, NV 89310 Ph: (775) 964-1232 |
News Archive
Responding to today's release of the Institute of Medicine 's (IOM) new report on the public health dimensions of the epilepsies, a cooperative group of professional and consumer organizations with special interest in epilepsy has issued the following joint statement.
Juno Therapeutics, Inc. announced today that the FDA has granted Orphan Drug Designation to its JCAR015 chimeric antigen receptor product candidate. The designation was granted for treatment of acute lymphoblastic leukemia. JCAR015 Phase I trials are currently underway at Juno's collaboration partner, Memorial Sloane Kettering Cancer Center.
A collaborative effort between researchers at the Salk Institute for Biological Studies and the University of California, San Diego, successfully used human induced pluripotent stem (iPS) cells derived from patients with Rett syndrome to replicate autism in the lab and study the molecular pathogenesis of the disease.
A team from KAIST has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM).
Although men have higher cancer mortality rates than women, they are less willing to be screened for cancer, according to a study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Sanoa Consulting LLC, Muscle Shoals, Ala., and the New York University College of Dentistry.
› Verified 1 days ago